Access cutting-edge rheumatoid arthritis treatment through this clinical trial at a research site in Tujunga. Study-provided care at no cost to qualified participants.
Access rheumatoid arthritis specialists in Tujunga at no cost
This study follows strict safety protocols and ethical guidelines
All study-related rheumatoid arthritis treatment provided free
This Phase 2b, multicenter, double-blind, placebo-controlled, randomized withdrawal study is designed to assess the efficacy and safety of IMVT-1402 in adult participants with active, difficult-to-treat, anti-citrullinated protein autoantibody (ACPA) positive rheumatoid arthritis (RA).
Sponsor: Immunovant Sciences GmbH
Check if you qualify for this rheumatoid arthritis clinical trial in Tujunga, CA
If you're searching for rheumatoid arthritis treatment options in Tujunga, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Tujunga research site is actively enrolling participants for this clinical trial. You'll receive care from experienced rheumatoid arthritis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.